September 30, 2026
Revenue Cycle Management Consulting: Why NC Practices Are Repricing Payer Contracts Before the 2027 Medicare Cut is the question facing North Carolina medical practices, specialty groups, diagnostic providers, and healthcare businesses as CMS prepares to finalize the CY 2027 Medicare Physician Fee Schedule.
The immediate answer is clear: practices should audit contracted rates, model payer profitability, and begin commercial contract repricing discussions now. Before the final rule is expected in November. CMS’s proposed rule projects a non-qualifying conversion factor of $32.84, a 1.68% decrease from the current factor, while qualifying APM participants face a projected 1.19% decrease to $33.17. The change is largely connected to the expiration of the one-year 2.5% statutory increase applied in 2026. CMS explains the proposed rate structure here.
The 2027 Medicare Proposal Creates a Contracting Deadline
A Medicare conversion-factor reduction does not automatically rewrite a commercial payer contract. However, it can influence reimbursement benchmarks, payer negotiation positions, and the economics of services priced as a percentage of Medicare or through RVU-based methodologies.
For North Carolina practices, the time to review contracts is before the reduction becomes operational, not after margins have already narrowed.
The North Carolina Healthcare Association’s 2026 mid-year report describes ongoing work involving denials, commercial insurance, Medicare Advantage plans, and broader billing and reimbursement issues. That environment reinforces a central business principle:
Accounting is history. Financing is forward looking.
Historical reports may show that a payer underpaid a claim last month. Forward-looking revenue cycle management consulting determines whether the contract itself is producing an acceptable return next year.
Audit Contract Economics Before Requesting Higher Rates
Many practices approach payer negotiations by requesting a general fee increase. A stronger strategy begins with service-line economics and documented contract performance.
What to Include in a Payer Contract Audit
A professional audit should compare the written contract, fee schedule, remittance data, and actual operating cost of delivering care.
✅ Reimbursement by CPT or HCPCS code
✅ Payment as a percentage of Medicare, if applicable
✅ Underpayment frequency and variance by payer
✅ Denial, recoupment, and appeal patterns
✅ Authorization and referral requirements
✅ Timely filing and appeal deadlines
✅ Patient responsibility collection rates
✅ Staffing, supplies, equipment, and facility costs
✅ Days from service to payment
✅ Volume concentration by payer and service line
The objective is not simply to identify the highest-paying payer. It is to identify which contracts generate sustainable contribution margins after administrative effort, clinical labor, supplies, technology, and delayed cash conversion are considered.
A contract that appears favorable on a fee schedule may become unprofitable when it requires excessive authorization work, produces frequent denials, or pays slowly.
“Why am I getting paid less than my contracted rate?”
“Why am I getting paid less than my contracted rate?” is one of the most important questions a practice can ask before renegotiating.
The answer may involve several different issues:
✅ The payer applied the wrong fee schedule or provider designation.
✅ A modifier, global-period rule, or bundling edit reduced payment.
✅ The contract permits a lower rate for a specific location or product.
✅ The claim was processed under an outdated enrollment record.
✅ The payer’s remittance advice does not match the negotiated methodology.
✅ The contract includes carve-outs, exclusions, or authorization conditions.
A revenue cycle management consulting review should separate true contractual underpayments from coding, eligibility, documentation, and claims-submission defects. That distinction matters because the remedy differs.
Contractual underpayments require payer escalation or renegotiation. Operational defects require process correction. Without that separation, management may negotiate aggressively for rates it is not consistently collecting, or overlook revenue that is already contractually owed.
“How do I know if my payer contracts are actually profitable?”
“How do I know if my payer contracts are actually profitable?” requires more than reviewing allowed amounts.
A payer contract should be evaluated against the full cost of serving that payer population. This includes direct clinical costs, revenue-cycle labor, denial follow-up, authorization time, technology expenses, supplies, equipment usage, and the delay between service delivery and payment.
Build a Payer Profitability Matrix
Healthcare executives and practice owners can begin with a payer profitability matrix that ranks contracts by:
✅ Net payment per encounter
✅ Contribution margin by service line
✅ Clean-claim rate
✅ Denial and appeal burden
✅ Average payment turnaround
✅ Administrative minutes per claim
✅ Patient responsibility realization
✅ Volume stability and referral value
✅ Exposure to future Medicare-linked adjustments
This analysis creates a defensible negotiation position. Instead of saying, “We need better rates,” the practice can explain which services are below sustainable thresholds and what contract terms would support continued access.
That is strategic capital management: directing clinical capacity toward financially viable services while protecting patient access and long-term stability.
Reprice Commercial Contracts With Specificity
Commercial payers are more likely to engage with a structured proposal than with a general request for “market adjustment.”
A practice should consider requesting:
✅ Updated conversion factors or fee schedules
✅ Annual inflation or cost-of-living adjustments
✅ Clear payment terms for new procedures and technology
✅ Defined rules for modifiers, multiple procedures, and site of service
✅ Faster resolution of disputed underpayments
✅ Limits on retroactive recoupments
✅ Reasonable authorization turnaround expectations
✅ Transparent escalation procedures
✅ Carve-outs for high-cost drugs, implants, or advanced equipment
The proposal should include supporting data from the practice’s own claims, remittances, operating costs, and patient access responsibilities. For North Carolina organizations operating in competitive or consolidating markets, contract leverage may also depend on specialty scarcity, geographic access, referral relationships, and the availability of alternative providers.
Recent reporting on the proposed Atrium Health–WakeMed combination shows how consolidation can reshape bargaining power, market competition, and reimbursement strategy across North Carolina. North Carolina Health News reported on the proposed combination and its potential market implications.
Independent practices should not wait for market consolidation to dictate their contract economics.
Use Cash Position Analysis to Time the Negotiation
Contract repricing is a forward-looking financial planning exercise, but negotiations may take weeks or months. Practices should model the cash position required to continue operating while revised terms are discussed.
Management should review:
✅ Current cash reserves
✅ Expected Medicare exposure in 2027
✅ Revenue concentration by payer
✅ Payroll and vendor obligations
✅ Capital expenditures already approved
✅ Contract renewal and termination dates
✅ Potential volume changes after repricing
✅ The financial effect of accepting or declining a payer’s proposal
If a practice identifies a contract that is unprofitable, it should model multiple scenarios: renegotiation, selective service restrictions, reduced payer volume, or termination where legally and operationally appropriate.
AR-Backed Working Capital Can Protect Negotiation Flexibility
Contract repricing is different from a liquidity strategy, but a temporary payment gap can complicate negotiations. A practice should not be forced to accept unfavorable contract terms simply because it lacks sufficient operating liquidity.
White Coat Financial Partners provides AR-Backed Working Capital through a non-notification lending model:
✅ The practice remains in full control of billing and collections.
✅ White Coat Financial Partners does not take possession of receivables.
✅ We do not contact patients or intervene in billing operations.
✅ Lending is based on the aggregate sum of monies due across total receivables, not individual claims.
✅ Repayment follows the practice’s cash flow and expected payment schedule.
✅ There is no compounding interest or open-ended discount rate.
✅ The structure is AR-backed rather than based solely on personal credit scores.
✅ The model can scale from solo practices to multi-location groups.
This approach can provide management with strategic breathing room while it audits payer economics, corrects underpayments, and negotiates from a position of clarity.
Pair Contract Strategy With Equipment Leasing
Payer repricing may reveal that a practice needs better technology, additional capacity, or more efficient diagnostic equipment to remain competitive. Equipment leasing can complement contract strategy by preserving cash for operations and negotiation periods.
A lease pays for the use of equipment rather than ownership, allowing a healthcare business to generate revenue without immediately absorbing full depreciation exposure or ownership risk. Purchase options may also allow practices to cycle into newer imaging, diagnostics, and AI-enabled tools at the end of the lease term.
Where applicable, operating leases may be recorded as expenses on the P&L rather than liabilities on the balance sheet, helping preserve debt capacity and debt-to-equity ratios. Lessees may also deduct the full lease payment as a business expense in the year of payment under IRS Section 179 (check with your tax advisor to see if you qualify).
The right structure depends on the organization’s accounting treatment, tax position, equipment needs, and long-term financial plan. The goal is to maintain capital flexibility while investing in revenue-producing capability.
FAQ: Revenue Cycle Management Consulting and Payer Contracts
When should a North Carolina practice start renegotiating payer contracts?
Practices should begin now, before CMS finalizes the CY 2027 Physician Fee Schedule. Early preparation allows time to audit claims, identify unprofitable services, review renewal windows, and develop a data-supported proposal.
Does the proposed Medicare cut automatically reduce commercial reimbursement?
No. The proposed Medicare conversion-factor changes do not automatically amend commercial contracts. The impact depends on the contract’s payment methodology, Medicare linkage, fee schedule language, and payer-specific terms.
What should a practice do if a payer refuses to reprice its contract?
Management should model the financial and operational consequences of maintaining the agreement, restricting selected services, pursuing alternative payer opportunities, or terminating where permitted. Legal and contractual review should precede any termination decision.
Prepare Before the Final Rule
North Carolina practices have a narrow planning window before the CY 2027 Medicare rule is expected to be finalized. A disciplined contract audit can reveal underpayments, administrative waste, and service lines that no longer support the organization’s financial health.
White Coat Financial Partners provides forward-looking financial planning, cash position analysis, payer economics guidance, AR-Backed Working Capital, and equipment leasing support for healthcare businesses. To discuss your organization’s strategic capital management plan, visit the Medical Practice Financing North Carolina landing page or call 910-688-5077.
Clarity in contract economics creates certainty in financial planning, and a stronger strategic advantage before 2027 begins.
About the Author
Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, equipment leasing, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability.